Persistent Asset Partners Ltd

Position in VKTX — Viking Therapeutics, Inc.

CIK 2056052 HONG KONG, K3

Back to VKTX Full portfolio

Position in VKTX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$4,329,967

+$1,145,685 QoQ

Shares Held

133,066

+47.0% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

1.71%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Mar 31, 2026

CallValue

$54,404

CallShares

1,672

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Persistent Asset Partners Ltd holds $59,094,384 across 109 Biotechnology names. VKTX ranks #1 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc. This page	133,066	$4,329,967
2	COGT	Cogent Biosciences, Inc.	92,516	$3,560,940
3	JAZZ	Jazz Pharmaceuticals plc	15,905	$3,006,840
4	ABVX	Abivax S.A.	22,838	$2,543,011
5	RVMD	Revolution Medicines, Inc.	26,043	$2,532,681
6	TERN	Terns Pharmaceuticals, Inc.	45,953	$2,422,642
7	BMRN	Biomarin Pharmaceutical Inc	37,472	$2,116,793
8	KOD	Kodiak Sciences Inc.	51,336	$1,956,928

All Filings in VKTX

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,329,967	133,066	+7858.5%	Shares	Sole	2026-05-12
2026-03-31	$54,404	1,672	-98.2%	Call	Sole	2026-05-12
2025-12-31	$3,184,282	90,514	+103.0%	Shares	Sole	2026-02-17
2025-09-30	$1,171,509	44,578	-2.0%	Shares	Sole	2026-01-15
2025-06-30	$1,205,273	45,482	+89.7%	Shares	Sole	2025-08-11
2025-03-31	$578,875	23,970	—	Shares	Defined	2025-05-13
No filing history on record for this holder in this stock.